ANA/NJ is a volunteer, nonprofit organization for acoustic neuroma patients, their families and friends. We have two important goals:
First, to provide support and information to patients before and after treatment. We do not give medical advice or referrals. Our members are available to meet with newly diagnosed patients and to encourage and share their own personal experiences.
Our second important goal is to increase public awareness of the symptoms of acoustic neuroma so that accurate and timely diagnosis can be assured.
Membership in ANA/NJ is open to anyone who has been affected by an acoustic neuroma and/or is interested in supporting the goals of the organization.
ANA/NJ holds two general meetings a year with speakers and programs of interest to acoustic neuroma patients, and we support local meetings planned by members in different areas of New Jersey.
We publish a semiannual newsletter and maintain a Directory of members and friends. Our series of biennial Mini-Conferences since 2008 has been temporarily placed on hold.
Welcome to ANA/NJ
the Acoustic Neuroma Association of New Jersey!
ANA/NJ News Flash
Virtual Care/Share meeting February 27. For details - Click Here
October 2021 ANA/NJ Virtual Meeting "Options for Better Hearing'
Meeting Report - Click Here
Video of the meeting - Click Here
Current ANA/NJ Newsletter
February 2022 Newsletter is now available - Click Here
ANA/NJ Virtual Meeting Report- "Caring and Sharing" - Click Here for Details
ANA/NJ Mini Conference April 2018 Summary Report - Click Here
Previous ANA/NJ Newsletter
October, 2021 Newsletter- Click Here
Index of Selected Newsletter Articles
April 2010 to present - Click Here
Membership Options - Click Here
Check us out on facebook!
Just go to "ANA/NJ" and become a member. You can visit, post, ask a question, exchange information, connect with acoustic neuroma friends. It's really cool!!! - Click Here to Open Facebook
Join the ANA/NJ Board
Help us provide support to AN Patients and their families. To see current Board Members - Click Here
Last Updated February 1, 2022